AB Science S.A., a pharmaceutical company, engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and veterinary medicines. The company markets Masitinib for the treatment of oncology and inflammatory diseases for dogs and cats. It markets its Masitinib under the Masivet brand name in Europe; and Kinavet brand name in the United States. The company is also developing Masitinib in human indications that are in various Phase II and Phase III studies for the treatment of oncology, inflammatory, and central nervous system diseases. It serves hospitals and specialist physicians. The company was founded in 2001 and is headquartered in Paris, France.
ab science sa (AB:EN Paris)
3, Avenue George V
Phone: 33 1 47 20 00 14
Fax: 33 1 47 20 24 11www.ab-science.com
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for AB.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact AB SCIENCE SA, please visit www.ab-science.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.